Cargando…
Anti-inflammatory properties of Type I interferons
The notion that Type I interferons (interferon-α and -β) possess anti-inflammatory potential is supported by data from clinical application in multiple sclerosis, by studies on cultured immune-competent cells and by investigation of experimental diseases in whole animals. These observations deserve...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114336/ https://www.ncbi.nlm.nih.gov/pubmed/16626815 http://dx.doi.org/10.1016/j.antiviral.2006.03.006 |
_version_ | 1783513864373010432 |
---|---|
author | Billiau, Alfons |
author_facet | Billiau, Alfons |
author_sort | Billiau, Alfons |
collection | PubMed |
description | The notion that Type I interferons (interferon-α and -β) possess anti-inflammatory potential is supported by data from clinical application in multiple sclerosis, by studies on cultured immune-competent cells and by investigation of experimental diseases in whole animals. These observations deserve the attention of virologists for their potential role in the pathogenesis and clinical management of virus infections. |
format | Online Article Text |
id | pubmed-7114336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71143362020-04-02 Anti-inflammatory properties of Type I interferons Billiau, Alfons Antiviral Res Mini-Review The notion that Type I interferons (interferon-α and -β) possess anti-inflammatory potential is supported by data from clinical application in multiple sclerosis, by studies on cultured immune-competent cells and by investigation of experimental diseases in whole animals. These observations deserve the attention of virologists for their potential role in the pathogenesis and clinical management of virus infections. Elsevier B.V. 2006-09 2006-04-04 /pmc/articles/PMC7114336/ /pubmed/16626815 http://dx.doi.org/10.1016/j.antiviral.2006.03.006 Text en Copyright © 2006 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Mini-Review Billiau, Alfons Anti-inflammatory properties of Type I interferons |
title | Anti-inflammatory properties of Type I interferons |
title_full | Anti-inflammatory properties of Type I interferons |
title_fullStr | Anti-inflammatory properties of Type I interferons |
title_full_unstemmed | Anti-inflammatory properties of Type I interferons |
title_short | Anti-inflammatory properties of Type I interferons |
title_sort | anti-inflammatory properties of type i interferons |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114336/ https://www.ncbi.nlm.nih.gov/pubmed/16626815 http://dx.doi.org/10.1016/j.antiviral.2006.03.006 |
work_keys_str_mv | AT billiaualfons antiinflammatorypropertiesoftypeiinterferons |